Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
NVIDIA
NVDA
|
$1B |
| 2 |
Netflix
NFLX
|
$721M |
| 3 |
Apple
AAPL
|
$468M |
| 4 |
UnitedHealth
UNH
|
$422M |
| 5 |
GE Vernova
GEV
|
$376M |
Top Sells
| 1 |
Broadcom
AVGO
|
$673M |
| 2 |
Robinhood
HOOD
|
$481M |
| 3 |
Meta Platforms (Facebook)
META
|
$433M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$402M |
| 5 |
Palantir
PLTR
|
$380M |
Sector Composition
| 1 | Technology | 19.67% |
| 2 | Healthcare | 15.34% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.51% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Motorsport Games
MSGM
$15.1M
| $84.7K | ﹤0.01% |
+29,200
| New | +$84.7K |
|
3327
Skillful Craftsman
EDTK
$16.6M
| $83.7K | ﹤0.01% |
96,700
-13,900
| -13% | -$12K |
|
3328
Vicarious Surgical
RBOT
$33.9M
| $83.5K | ﹤0.01% |
11,134
-1,500
| -12% | -$11.3K |
|
3329
KALA BIO
KALA
$102M
| $82.8K | ﹤0.01% |
+17,400
| New | +$82.8K |
|
3330
CVRx
CVRX
$204M
| $82.3K | ﹤0.01% |
+14,000
| New | +$82.3K |
|
|
GRCE
3331
Grace Therapeutics, Inc. Common Stock
GRCE
$44.3M
| $82K | ﹤0.01% |
27,625
-14,556
| -35% | -$43.2K |
|
3332
VistaGen Therapeutics
VTGN
$109M
| $81K | ﹤0.01% |
40,500
+15,700
| +63% | +$31.4K |
|
|
YQ
3333
17 Education & Technology Group
YQ
$19.5M
| $80.7K | ﹤0.01% |
36,830
+15,600
| +73% | +$34.2K |
|
3334
Coya Therapeutics
COYA
$105M
| $80.5K | ﹤0.01% |
14,000
+1,800
| +15% | +$10.4K |
|
|
IMDX
3335
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$71M
| $78.8K | ﹤0.01% |
+26,100
| New | +$78.8K |
|
|
SBFM
3336
Sunshine Biopharma
SBFM
$6.15M
| $77.9K | ﹤0.01% |
+54,093
| New | +$77.9K |
|
3337
ClearOne
CLRO
$8.52M
| $77.3K | ﹤0.01% |
13,447
-1,081
| -7% | -$6.22K |
|
|
SOHO
3338
Sotherly Hotels
SOHO
$17M
| $76.7K | ﹤0.01% |
80,714
+200
| +0.2% | +$190 |
|
3339
Alto Neuroscience
ANRO
$99.4M
| $76.3K | ﹤0.01% |
+34,700
| New | +$76.3K |
|
3340
Urban One Class A
UONE
$73.5M
| $75.5K | ﹤0.01% |
47,200
+100
| +0.2% | +$160 |
|
|
PCLA
3341
PicoCELA Inc. American Depositary Shares
PCLA
$15.1M
| $74K | ﹤0.01% |
+45,700
| New | +$74K |
|
3342
Armata Pharmaceuticals
ARMP
$103M
| $73.9K | ﹤0.01% |
38,896
+300
| +0.8% | +$570 |
|
3343
Elutia
ELUT
$79.7M
| $73.3K | ﹤0.01% |
37,016
-700
| -2% | -$1.39K |
|
3344
Wrap Technologies
WRAP
$86.9M
| $73K | ﹤0.01% |
+46,800
| New | +$73K |
|
3345
Athira Pharma
ATHA
$15.4M
| $72.8K | ﹤0.01% |
241,000
+22,000
| +10% | +$6.64K |
|
3346
Performance Shipping
PSHG
$23.5M
| $72.8K | ﹤0.01% |
41,584
+13,184
| +46% | +$23.1K |
|
|
SOGP
3347
Sound Group
SOGP
$137M
| $72K | ﹤0.01% |
15,158
| – | – |
|
|
INCR
3348
Intercure
INCR
$86.1M
| $71.9K | ﹤0.01% |
48,900
+500
| +1% | +$735 |
|
3349
Atlantic American Corp
AAME
$66.7M
| $71.1K | ﹤0.01% |
33,400
+300
| +0.9% | +$639 |
|
3350
Grove Collaborative
GROV
$62.7M
| $70.8K | ﹤0.01% |
61,600
+5,200
| +9% | +$5.98K |
|